Mobiluncus species

If bacterial vaginosis keeps coming back for you, this result may point to one reason. In a study that followed women after standard antibiotic treatment, about two thirds of those who still carried Mobiluncus curtisii had the infection return within roughly ten weeks. Among women who had cleared it, about one in nine did (67.9% versus 11.4%).

Mobiluncus spp. (Mobiluncus species) are curved bacteria that live without oxygen. This swab reports how many of them are in your vaginal sample. BV is diagnosed with bedside criteria (Amsel criteria) and Gram stain scoring, and no validated diagnostic or treatment approach uses a Mobiluncus count on its own. No one has agreed on cutoffs for how much is too much yet, so the number works best as a personal comparison point read alongside the rest of your vaginal microbiome.

Two Species, Both Worth Watching

Two species turn up in vaginal samples. Mobiluncus mulieris is the more common one, and low levels show up fairly often in women whose vaginal flora is otherwise healthy. It still isn't harmless. It carried about five times the odds of BV in the Ecuadorian study below, and it's the species tied to miscarriage in an exploratory analysis. Mobiluncus curtisii is rarely found outside BV, resists metronidazole more often, and is the one linked to BV coming back after treatment. For both species, what matters most is how much is there and what the rest of the flora looks like.

A healthy vagina is usually dominated by Lactobacillus. These bacteria keep the environment acidic and crowd out other organisms. When they lose ground, a mix of bacteria that live without oxygen takes over. When that shift causes symptoms like thin discharge and a fishy odor, it's called bacterial vaginosis (BV), and Mobiluncus is one of the organisms that usually comes with it.

Bacterial Vaginosis

Mobiluncus is far more common when BV is present. Studies have found it in 65% to 85% of women with BV. In women without BV, estimates run from under 5% to 38%, depending mostly on how sensitive the detection method was.

In a study of 414 Ecuadorian women, carrying M. mulieris came with about five times the odds of a BV diagnosis (adjusted odds ratio 4.98). In a large study of pregnant women with BV, the ones who also carried Mobiluncus more often had clue cells on microscopy (63.9% versus 47.2%) and a positive odor test (57.2% versus 45.0%). Clue cells are vaginal lining cells coated in bacteria, and they're one of the standard signs of BV.

Pregnant women with BV who carried Mobiluncus also had higher vaginal levels of sialidase. That enzyme breaks down the mucus layer that protects the vaginal lining. So carrying Mobiluncus tends to go along with a more advanced, more symptomatic form of BV.

What this means for you: if your count is high and the same panel shows low Lactobacillus or a positive BV result, the findings agree. Together they point to active BV that's worth treating, especially if you have symptoms.

Why BV Comes Back After Treatment

Metronidazole is the usual first antibiotic for BV, and M. curtisii often survives it. In lab testing of isolates from a Turkish series, more than 80% of Mobiluncus isolates resisted metronidazole, and M. curtisii was the more resistant of the two species. The recurrence figures in the opening come from women treated with oral metronidazole and rechecked 65 to 70 days later, so the lab resistance seems to show up in real outcomes too.

A repeat swab after treatment shows whether Mobiluncus cleared. If your report gives one figure for both species, it can't confirm that M. curtisii specifically persisted. If the count stays up, ask whoever prescribes your treatment about a different approach before symptoms return. Choosing a different antibiotic is a prescription decision.

Pregnancy, Preterm Birth, and Miscarriage

Several studies have looked at Mobiluncus in early pregnancy. The findings are consistent enough to take seriously, but each one comes from a specific group of women.

Sources: Nelson et al. 2014; Holst et al. 1994; McClelland et al. 2024.

What this means for you: if you've had a preterm birth before, or you're planning a pregnancy, a count taken before or early in pregnancy gives you something concrete to bring to your obstetrician. None of these studies tested whether clearing Mobiluncus prevents preterm birth or miscarriage. A high result is a reason for closer monitoring, and it can't tell you how a pregnancy will go.

Healthy Carriers and High Counts

Sensitive DNA testing has found Mobiluncus in up to 38% of women who don't have BV, and most of it was M. mulieris. That can look like it contradicts everything above. The findings fit together once you read the result as a question of amount and context. Low levels of Mobiluncus often sit quietly in healthy vaginas. Problems tend to appear when the count climbs and Lactobacillus has lost ground at the same time, and that applies to both species. M. curtisii adds the extra problem of resisting treatment and predicting recurrence.

Treating a finding that isn't an infection has costs. In community clinics, women who were treated without an infection being found ended up back for more visits within 90 days. If your count is low and the rest of your flora looks healthy, the sensible move is to retest later.

Is It Sexually Transmitted?

Mobiluncus isn't classed as a sexually transmitted infection, and where it comes from is still debated. An older study recovered BV-linked organisms, Mobiluncus among them, from the rectum and concluded that the vagina is probably colonized from the person's own gut. A later study of 18 adolescent males found Mobiluncus and other BV-linked bacteria on the penis, some apparently picked up through sex.

The practical point is that these bacteria can return from places outside the vagina, which may help explain recurrence. BV itself goes with higher rates of chlamydia and gonorrhea, roughly 1.8 and 1.9 times the risk in high-risk groups. That figure comes from research on BV as a whole and wasn't measured for Mobiluncus specifically.

Microscope Results Versus Direct Counts

For decades, labs identified Mobiluncus by spotting curved rods on a Gram stain. A Gram stain is a dye test read under a microscope, and it produces the Nugent score, the standard 0 to 10 grading of vaginal flora. Later DNA work showed that in the most abnormal smears, most of those curved rods belong to a different organism, BV-associated bacterium 1 (BVAB1), which outnumbered Mobiluncus by roughly 100 times.

Microscopy also misses a lot of true Mobiluncus that DNA testing picks up. A Nugent report that mentions curved rods and a direct Mobiluncus count measure different things, and they can disagree.

Many commercial BV panels leave Mobiluncus out of their scoring and rely on markers like Atopobium vaginae, Megasphaera, and a second BV-associated bacterium called BVAB2. Standard STI screens don't look at vaginal flora at all. A normal result on either one tells you nothing direct about your Mobiluncus level.

When a Single Result Can Mislead

• Recent antibiotics: a metronidazole course pushes BV bacteria down within days, but in a small study of seven women several of them rebounded soon after treatment ended. A swab taken during or right after treatment can look cleaner than your flora will a few weeks later.
• Different methods, different numbers: this result is an estimated bacterial count, reported in units of 10^5 per gram of sample, and labs use different counting techniques. Results from another lab, a Gram stain, or a sequencing report that gives percentages can't be compared directly with this one.
• One number for two species: if your report gives a single figure for Mobiluncus as a whole, it can't tell you whether the bacteria are mostly M. mulieris or the harder-to-treat M. curtisii, the species behind the recurrence findings above.

Tracking Your Trend

Vaginal flora shifts over time, and BV bacteria rise and fall sharply around treatment, so one swab is only a snapshot. With no agreed cutoffs, the comparison that tells you the most is your own result before and after something changes, such as finishing a course of antibiotics or starting a probiotic.